Sectoral Asset Management’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-92,240
Closed -$939K 98
2024
Q1
$939K Sell
92,240
-78,560
-46% -$799K 0.37% 57
2023
Q4
$1.92M Buy
+170,800
New +$713K 0.83% 47
2023
Q2
Sell
-479,100
Closed -$2.02M 123
2023
Q1
$2.02M Buy
479,100
+136,600
+40% +$1.62M 0.39% 81
2022
Q4
$5.63M Buy
342,500
+73,400
+27% +$824K 1.09% 37
2022
Q3
$3.44M Buy
269,100
+119,100
+79% +$1.76M 0.68% 64
2022
Q2
$1.75M Buy
+150,000
New +$925K 0.35% 84

Other funds holding ALT

Sectoral Asset Management's ALT Position: Q2 2024 in Review

Sectoral Asset Management sold out of Altimmune (ALT) in Q2 2024, closing a stake of 92,240 shares — an estimated $939K sold.

Sectoral Asset Management first reported a position in ALT in Q2 2022 and held it in 6 quarters. The position peaked at $5.63M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Sectoral Asset Management reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 92,240 Altimmune shares in Q2 2024, an estimated $939K.
  • Sectoral Asset Management first reported a position in Altimmune in Q2 2022 and held it in 6 quarters.
  • Sectoral Asset Management's Altimmune position peaked at $5.63M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Sectoral Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.